(BSCV) Invesco BulletShares 2031 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138J4296

BSCV: Corporate, Bonds, 2031, Maturity, Investment-Grade

The Invesco BulletShares 2031 Corporate Bond ETF (BSCV) is a target maturity ETF that focuses on investing at least 80% of its assets in a portfolio of U.S. dollar-denominated investment-grade corporate bonds maturing in 2031. This ETF is designed to provide investors with a predictable income stream and a relatively stable return profile as the bonds approach maturity.

From a technical analysis perspective, the ETFs price action indicates a stable trend, with the short-term and long-term moving averages (SMA20, SMA50, and SMA200) converging, suggesting a potential breakout. The Average True Range (ATR) of 0.10 (0.61%) implies relatively low volatility, making it an attractive option for risk-averse investors. Given the current price of $16.39, a potential target price could be $16.50, based on the ETFs historical price movement and the upcoming maturity of the underlying bonds.

Fundamentally, the ETFs Assets Under Management (AUM) of $982.08 million indicate a moderate level of investor interest. As the underlying bonds approach maturity in 2031, the ETF is likely to distribute the principal amount to investors, providing a predictable cash flow. Assuming interest rates remain stable or decline, the ETFs yield is likely to remain attractive, potentially driving investor demand and supporting the ETFs price.

Forecasting the ETFs performance, we can expect the price to remain stable or increase slightly as the underlying bonds approach maturity. Based on the technical data, a potential price target of $16.60 is possible, representing a 1.3% increase from the current price. Additionally, the ETFs yield is likely to remain competitive, attracting income-seeking investors and supporting the ETFs AUM. As the maturity date approaches, the ETFs price is likely to converge with its net asset value, providing a relatively stable return profile for investors.

Additional Sources for BSCV ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BSCV ETF Overview

Market Cap in USD 1,037m
Category Target Maturity
TER 0.10%
IPO / Inception 2021-09-15

BSCV ETF Ratings

Growth Rating 14.7
Fundamental -
Dividend Rating 76.1
Rel. Strength -5.68
Analysts -
Fair Price Momentum 16.41 USD
Fair Price DCF -

BSCV Dividends

Dividend Yield 12m 4.42%
Yield on Cost 5y 4.19%
Annual Growth 5y 53.19%
Payout Consistency 100.0%
Payout Ratio %

BSCV Growth Ratios

Growth Correlation 3m 76.6%
Growth Correlation 12m 67.4%
Growth Correlation 5y 20.1%
CAGR 5y -0.96%
CAGR/Max DD 5y -0.04
Sharpe Ratio 12m 1.36
Alpha 3.68
Beta 0.007
Volatility 5.50%
Current Volume 281.5k
Average Volume 20d 229.4k
What is the price of BSCV shares?
As of June 29, 2025, the stock is trading at USD 16.47 with a total of 281,530 shares traded.
Over the past week, the price has changed by +0.75%, over one month by +1.58%, over three months by +2.74% and over the past year by +7.94%.
Is Invesco BulletShares 2031 a good stock to buy?
Neither. Based on ValueRay´s Analyses, Invesco BulletShares 2031 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 14.68 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BSCV is around 16.41 USD . This means that BSCV is currently overvalued and has a potential downside of -0.36%.
Is BSCV a buy, sell or hold?
Invesco BulletShares 2031 has no consensus analysts rating.
What are the forecasts for BSCV share price target?
According to our own proprietary Forecast Model, BSCV Invesco BulletShares 2031 will be worth about 17.7 in June 2026. The stock is currently trading at 16.47. This means that the stock has a potential upside of +7.59%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 17.7 7.6%